Neuberger Berman Group
LFCR icon

Neuberger Berman Group’s Lifecore Biomedical LFCR Stock Holding History

Neuberger Berman Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-27,275
Closed -$344K – 1714
2017
Q4 		$344K Sell
27,275
-13,450
-33% -$170K ﹤0.01% 1503
2017
Q3 		$527K Sell
40,725
-11,500
-22% -$152K ﹤0.01% 1294
2017
Q2 		$776K Sell
52,225
-6,200
-11% -$86.3K ﹤0.01% 1214
2017
Q1 		$701K Sell
58,425
-1,500
-3% -$19K ﹤0.01% 1223
2016
Q4 		$827K Buy
59,925
+17,825
+42% +$247K ﹤0.01% 1181
2016
Q3 		$565K Buy
+42,100
New +$510K ﹤0.01% 1239

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

Neuberger Berman Group's LFCR Position: Q1 2018 in Review

Neuberger Berman Group sold out of Lifecore Biomedical (LFCR) in Q1 2018, closing a stake of 27,275 shares — an estimated $344K sold.

Neuberger Berman Group first reported a position in LFCR in Q3 2016 and held it in 6 quarters. The position peaked at $827K in Q4 2016. 89 funds tracked by Wall St. Rank hold LFCR as of Q1 2018.

  • Neuberger Berman Group reported no remaining Lifecore Biomedical position as of Q1 2018 after selling out during the quarter.
  • Neuberger Berman Group sold 27,275 Lifecore Biomedical shares in Q1 2018, an estimated $344K.
  • Neuberger Berman Group first reported a position in Lifecore Biomedical in Q3 2016 and held it in 6 quarters.
  • Neuberger Berman Group's Lifecore Biomedical position peaked at $827K in Q4 2016.
  • 89 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2018.

Based on Neuberger Berman Group's 13F filing for Q1 2018, filed 8 May 2018.